OPAM Workshop: Medical Review Officer Training Course: Toxicology Testing and the MRO, A Physician's Role in the Prevention and Treatment of Substance Abuse-285274

Video Transcription

Video Summary

The video presented by Donna Smith from Workforce QA covers the Department of Transportation's (DOT) drug testing rules, emphasizing confidentiality, service agents, and the differences among DOT agencies. Donna, a Regulatory Compliance Officer at Workforce QA, explains the origins and development of these regulations, noting their influence by Department of Health and Human Services guidelines since 1988, with implementation commencing in 1990. The rules target Schedule I and II drug deterrence, alcohol testing since 1995, and include various mandatory testing types like pre-employment, post-accident, and random tests.<br /><br />Over the years, regulations have expanded to incorporate alcohol testing, intrastate commercial drivers, and the recent approval for oral fluid testing, pending lab certifications. Different DOT agencies manage testing for specific sectors, with varied requirements and consequences for non-compliance. Employers must adhere to multiple testing types and confidentiality measures, maintaining separate records for DOT and non-DOT tests. Regulations mandate clear responsibilities for employers and service agents, including Medical Review Officers and Third Party Administrators, with structured reporting and confidentiality protocols. Such measures ensure safety and regulatory compliance within safety-sensitive sectors of the transportation industry.

Keywords

DOT drug testing

confidentiality

service agents

regulatory compliance

Schedule I and II drugs

alcohol testing

oral fluid testing

Medical Review Officers

transportation industry